WASHINGTON — Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Food and Drug Administration (FDA) Acting Commissioner Kyle Diamantas raising concerns that the FDA’s long-promised safety study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results